EE102 Economic Burden of Short-Acting Beta-2 Agonist Overuse Among Asthma Patients in Turkiye: A Cost Analysis with Respect to Updated Recommendations of the Global Initiative for Asthma
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.373
https://www.valueinhealthjournal.com/article/S1098-3015(23)03503-9/fulltext
Title :
EE102 Economic Burden of Short-Acting Beta-2 Agonist Overuse Among Asthma Patients in Turkiye: A Cost Analysis with Respect to Updated Recommendations of the Global Initiative for Asthma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03503-9&doi=10.1016/j.jval.2023.09.373
First page :
Section Title :
Open access? :
No
Section Order :
12399